Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Xia, Feng ^a   Wu, Lin ^a   Lau, Wan Yee ^a,b   Li, Guo ^a   Huan, Hongbo ^a   Qian, Cheng ^a   Ma, Kuansheng ^a   Bie, Ping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD PUGH SCORE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER VEIN; LONG TERM SURVIVAL; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PORTAL VEIN; PROTHROMBIN TIME; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; TUMOR INVASION; TUMOR LOCALIZATION; VERY ELDERLY; BONE TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC USE; LIVER TUMOR; LUNG TUMOR; LYMPH NODE; MIDDLE AGED; MORTALITY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SCINTISCANNING; SECONDARY; SURVIVAL;

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CARCINOMA, HEPATOCELLULAR; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 84899713521     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095889     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Katyal S, Oliver JH 3rd, Peterson MS, Ferris JV, Carr BS, et al. (2000) Extrahepatic metastases of hepatocellular carcinoma. Radiology 216: 698-703. (Pubitemid 30660840)
3. Shuto T, Hirohashi K, Kubo S, Tanaka H, Yamamoto T, et al. (2001) Treatment of adrenal metastases after hepatic resection of a hepatocellular carcinoma. Dig Surg 18: 294-297. (Pubitemid 32786152)
4. Si MS, Amersi F, Golish SR, Ortiz JA, Zaky J, et al. (2003) Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival. Am Surg 69: 879-885.
5. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576. (Pubitemid 46890874)
6. Yoon KT, Kim JK, Kim do Y, Ahn SH, Lee JD, et al. (2007) Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Oncology 72 Suppl 1: 104-110. (Pubitemid 350256673)
7. Llovet JM, Real MI, Montana X, Planas R, Coll S, et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359: 1734-1739. (Pubitemid 34607087)
8. Kim YK, Lee KW, Cho SY, Han SS, Kim SH, et al. (2010) Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Liver Transpl 16: 767-772.
9. Kawaoka T, Aikata H, Takaki S, Uka K, Azakami T, et al. (2009) FDG positron emission tomography/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma. Hepatol Res 39: 134-142.
10. He YX, Guo QY (2008) Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms. Postgrad Med J 84: 246-251.
11. Wudel LJ Jr, Delbeke D, Morris D, Rice M, Washington MK, et al. (2003) The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg 69: 117-124; discussion 124-116.
12. Ho CL, Chen S, Yeung DW, Cheng TK (2007) Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med 48: 902-909. (Pubitemid 46909918)
13. Sugiyama M, Sakahara H, Torizuka T, Kanno T, Nakamura F, et al. (2004) 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol 39: 961-968. (Pubitemid 39490173)
14. Lin CY, Chen JH, Liang JA, Lin CC, Jeng LB, et al. (2012) 18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis. Eur J Radiol 81: 2417-2422.
15. Natsuizaka M, Omura T, Akaike T, Kuwata Y, Yamazaki K, et al. (2005) Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 20: 1781-1787. (Pubitemid 43961087)
16. Ochiai T, Ikoma H, Okamoto K, Kokuba Y, Sonoyama T, et al. (2012) Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection. World J Surg 36: 136-143.
17. Tanaka K, Shimada H, Matsuo K, Takeda K, Nagano Y, et al. (2008) Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection. World J Surg 32: 1738-1747.
18. Chan KM, Yu MC, Wu TJ, Lee CF, Chen TC, et al. (2009) Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J Gastroenterol 15: 5481-5488.
19. Taketomi A, Toshima T, Kitagawa D, Motomura T, Takeishi K, et al. (2010) Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 17: 2740-2746.
20. Sun HC, Zhuang PY, Qin LX, Ye QH, Wang L, et al. (2007) Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol 96: 37-45. (Pubitemid 47015447)
21. (1990) Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 211: 277-287.
22. Lee CW, Chan KM, Lee CF, Yu MC, Lee WC, et al. (2011) Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome. Asian J Surg 34: 53-62.
23. Xiaohong S, Huikai L, Feng W, Ti Z, Yunlong C, et al. (2010) Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg 34: 1028-1033.
24. Ercolani G, Grazi GL, Ravaioli M, Grigioni WF, Cescon M, et al. (2004) The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 239: 202-209. (Pubitemid 38176354)
25. Uka K, Aikata H, Takaki S, Shirakawa H, Jeong SC, et al. (2007) Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 13: 414-420. (Pubitemid 46178976)
26. Lee CY, Bae MK, Park IK, Kim DJ, Lee JG, et al. (2010) Surgical resection for pulmonary metastasis from hepatocellular carcinoma: analysis of prognosis in relation to primary control. J Surg Oncol 101: 239-243.
27. Sakamoto M, Murakawa T, Kitano K, Murayama T, Tsuchiya T, et al. (2010) Resection of solitary pulmonary lesion is beneficial to patients with a history of malignancy. Ann Thorac Surg 90: 1766-1771.
28. Yoon YS, Kim HK, Kim J, Choi YS, Shim YM, et al. (2010) Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 17: 2795-2801.
29. Kitano K, Murayama T, Sakamoto M, Nagayama K, Ueno K, et al. (2012) Outcome and survival analysis of pulmonary metastasectomy for hepatocellular carcinoma. Eur J Cardiothorac Surg 41: 376-382.